• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

试验管理:我们需要一批高素质的临床试验人员来提供患者所需的答案。

Trial management: we need a cadre of high-class triallists to deliver the answers that patients need.

机构信息

Clinical Trials Unit, Department of Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.

出版信息

Trials. 2019 Jun 13;20(1):354. doi: 10.1186/s13063-019-3451-z.

DOI:10.1186/s13063-019-3451-z
PMID:31196151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6567635/
Abstract

Expert trial managers with the training and experience to overcome operational challenges are often the difference between the success and failure of a clinical trial. Considerable importance is given to the beginning and the end of the clinical trial process, with those responsible for writing a protocol, obtaining funding and analysing the data all being rewarded when the results are published. Yet, trial managers are often overlooked in terms of recognition, value and status. This article highlights some of the key barriers to achieving this and makes suggestions on how they can be addressed within clinical trials units registered with the UK Clinical Research Collaboration.

摘要

具有克服运营挑战的培训和经验的专家试验经理通常是临床试验成功与否的关键。临床试验过程的开始和结束都受到相当大的重视,当结果公布时,负责撰写方案、获得资金和分析数据的人都会得到回报。然而,试验经理在认可、价值和地位方面往往被忽视。本文重点介绍了实现这一目标的一些关键障碍,并就如何在英国临床研究合作组织注册的临床试验单位解决这些问题提出了建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b664/6567635/bf6bbe30b12a/13063_2019_3451_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b664/6567635/134cea96c4b9/13063_2019_3451_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b664/6567635/bf6bbe30b12a/13063_2019_3451_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b664/6567635/134cea96c4b9/13063_2019_3451_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b664/6567635/bf6bbe30b12a/13063_2019_3451_Fig2_HTML.jpg

相似文献

1
Trial management: we need a cadre of high-class triallists to deliver the answers that patients need.试验管理:我们需要一批高素质的临床试验人员来提供患者所需的答案。
Trials. 2019 Jun 13;20(1):354. doi: 10.1186/s13063-019-3451-z.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
What are the main inefficiencies in trial conduct: a survey of UKCRC registered clinical trials units in the UK.试验实施中的主要低效因素有哪些:对英国UKCRC注册的临床试验单位的一项调查。
Trials. 2018 Jan 8;19(1):15. doi: 10.1186/s13063-017-2378-5.
4
Where do we go from here? - Opportunities and barriers to the career development of trial managers: a survey of UK-based trial management professionals.我们接下来该怎么做?- 临床试验管理人员职业发展的机遇与障碍:对英国临床试验管理专业人员的调查。
Trials. 2020 May 6;21(1):384. doi: 10.1186/s13063-020-04316-z.
5
Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review.评估指定随机对照试验目标差值的方法:DELTA(试验中差值确定)综述。
Health Technol Assess. 2014 May;18(28):v-vi, 1-175. doi: 10.3310/hta18280.
6
Publishing protocols for trials of complex interventions before trial completion - potential pitfalls, solutions and the need for public debate.在试验完成前发布复杂干预措施试验的方案——潜在陷阱、解决方案及公开辩论的必要性。
Trials. 2017 Jan 9;18(1):5. doi: 10.1186/s13063-016-1757-7.
7
Learning from OCTET - exploring the acceptability of clinical trials management methods.从OCTET研究中学习——探索临床试验管理方法的可接受性。
Trials. 2018 Jul 13;19(1):378. doi: 10.1186/s13063-018-2765-6.
8
This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols.这是一个平台变更:从试验管理的角度来看,适应性和平台及伞式方案的操作方面。
Trials. 2019 May 29;20(1):264. doi: 10.1186/s13063-019-3216-8.
9
Time to STEP UP: methods and findings from the development of guidance to help researchers design inclusive clinical trials.加快步伐:制定指导方针以帮助研究人员设计包容性临床试验的方法和研究结果。
BMC Med Res Methodol. 2024 Oct 2;24(1):227. doi: 10.1186/s12874-024-02342-y.
10
Consensus workshops on the development of an ADHD medication management protocol using QbTest: developing a clinical trial protocol with multidisciplinary stakeholders.使用 QbTest 制定 ADHD 药物管理方案的共识研讨会:与多学科利益相关者共同制定临床试验方案。
BMC Med Res Methodol. 2019 Jun 18;19(1):126. doi: 10.1186/s12874-019-0772-2.

引用本文的文献

1
Systematic Review of Women Leading and Participating in Nephrology Randomized Clinical Trials.女性主导和参与肾脏病学随机临床试验的系统评价。
Kidney Int Rep. 2024 Jan 28;9(4):898-906. doi: 10.1016/j.ekir.2024.01.031. eCollection 2024 Apr.
2
Conducting Digital Health Care Research: Document Analysis of Challenges Experienced During Intervention Development and Feasibility Study Setup of an Internet-Administered Intervention for Parents of Children Treated for Cancer.开展数字医疗保健研究:对一项针对癌症患儿家长的互联网管理干预措施在干预开发和可行性研究设置过程中所面临挑战的文献分析。
JMIR Form Res. 2021 Oct 8;5(10):e26266. doi: 10.2196/26266.
3

本文引用的文献

1
Doing trials within trials: a qualitative study of stakeholder views on barriers and facilitators to the routine adoption of methodology research in clinical trials.在试验中进行试验:一项关于利益相关者对临床试验中方法学研究常规采用的障碍和促进因素看法的定性研究。
Trials. 2018 Sep 10;19(1):481. doi: 10.1186/s13063-018-2862-6.
2
Women's work in UK clinical trials is undervalued.英国临床试验中女性的工作被低估了。
Lancet. 2018 Sep 1;392(10149):732. doi: 10.1016/S0140-6736(18)31540-X.
3
The gendered system of academic publishing.学术出版的性别化体系。
Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors.
与女性作为第一作者代表性不足相关的心力衰竭试验特征。
J Am Coll Cardiol. 2020 Oct 27;76(17):1919-1930. doi: 10.1016/j.jacc.2020.08.062.
4
Where do we go from here? - Opportunities and barriers to the career development of trial managers: a survey of UK-based trial management professionals.我们接下来该怎么做?- 临床试验管理人员职业发展的机遇与障碍:对英国临床试验管理专业人员的调查。
Trials. 2020 May 6;21(1):384. doi: 10.1186/s13063-020-04316-z.
Lancet. 2018 May 5;391(10132):1754-1756. doi: 10.1016/S0140-6736(18)30950-4.
4
A systematic analysis of UK cancer research funding by gender of primary investigator.按主要研究者性别对英国癌症研究资金进行的系统分析。
BMJ Open. 2018 Apr 30;8(4):e018625. doi: 10.1136/bmjopen-2017-018625.
5
Gender inequity in speaking opportunities at the American Geophysical Union Fall Meeting.美国地球物理联合会秋季会议上的发言机会性别不平等。
Nat Commun. 2018 Apr 24;9(1):1358. doi: 10.1038/s41467-018-03809-5.
6
Trial Forge Guidance 1: what is a Study Within A Trial (SWAT)?试验构建指南1:试验中的研究(SWAT)是什么?
Trials. 2018 Feb 23;19(1):139. doi: 10.1186/s13063-018-2535-5.
7
Successful recruitment to trials: findings from the SCIMITAR+ Trial.临床试验的成功招募:来自 SCIMITAR+ 试验的结果。
Trials. 2018 Jan 19;19(1):53. doi: 10.1186/s13063-018-2460-7.
8
Lessons from the field: the conduct of randomized controlled trials in Botswana.实地经验:博茨瓦纳随机对照试验的实施
Trials. 2017 Oct 27;18(1):503. doi: 10.1186/s13063-017-2237-4.
9
Recognition matters: only one in ten awards given to women.认可度很重要:授予女性的奖项只有十分之一。
Lancet. 2017 Jun 24;389(10088):2469. doi: 10.1016/S0140-6736(17)31592-1.
10
Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.氨甲环酸早期给药对产后出血妇女死亡率、子宫切除术和其他并发症的影响(WOMAN):一项国际、随机、双盲、安慰剂对照试验。
Lancet. 2017 May 27;389(10084):2105-2116. doi: 10.1016/S0140-6736(17)30638-4. Epub 2017 Apr 26.